Komori
OPTiM (3694) · RiskRestated

Uncertainty in R&D Investment Projections

First written in FY2016. 5 of 6 entries say "Restated". Latest entry: FY2024.

6entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20242016: 120162017: 020172018: 120182019: 120192020: 020202021: 120212022: 120222023: 020232024: 12024
Same theme, other companies
Risk of R&D investments failing to deliver resultsA theme 116 companies write about · 116 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 14 of 29 companies on the "Worse" side.

74 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 116 companies compared. The sentences above are computed from all 116.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「R&D policies are determined based on forecasts of user needs and competitors’ trends, informed by research and reports. If these forecasts prove materially inaccurate or the Group must change its R&D policy, the Group’s business and operating performance could be affected.」

    The Company continues to face uncertainty in forecasting R&D investment and the risk of impacts arising from changes in its R&D policy.
  2. FY2022RestatedAnnual report

    「R&D policies are determined based on forecasts of user needs and competitors’ trends, informed by research and reports. If these forecasts prove materially inaccurate or the Group must change its R&D policy, the Group’s business and operating performance could be affected.」

    The Company continues to face uncertainty in forecasting R&D investment and the risk of impacts arising from changes in its R&D policy.
  3. FY2021RestatedAnnual report

    「R&D policies are determined based on forecasts of user needs and competitors’ trends, informed by research and reports. If these forecasts prove materially inaccurate or the Group must change its R&D policy, the Group’s business and operating performance could be affected.」

    The Company continues to face uncertainty in forecasting R&D investment and the risk of changing its R&D policy.
  4. FY2019RestatedAnnual report

    「The Company operates a business model based not merely on contract development but on licensing technologies it develops in-house, and allocates a substantial budget to the R&D that supports this model. R&D policies are determined based on forecasts of user needs and competitors’ trends, informed by research and reports. If these forecasts prove materially inaccurate or the Company must change its R&D policy, its business and operating performance could be affected.」

    The Company continues to face uncertainty in forecasting R&D investment and the risk of impacts arising from changes in its R&D policy.
  5. FY2018RestatedAnnual report

    「The Company operates a business model based not merely on contract development but on licensing technologies it develops in-house, and allocates a substantial budget to the R&D that supports this model. R&D policies are determined based on forecasts of user needs and competitors’ trends, informed by research and reports. If these forecasts prove materially inaccurate or the Company must change its R&D policy, its business and operating performance could be affected.」

    The Company continues to face uncertainty in forecasting R&D investment and the risk of changing its R&D policy.
  6. FY2016First statedAnnual report

    「The Company operates a business model based not merely on contract development but on licensing technologies it develops in-house, and allocates a substantial budget to the R&D that supports this model. R&D policies are determined based on forecasts of user needs and competitors’ trends, informed by research and reports. If these forecasts prove materially inaccurate or the Company must change its R&D policy, its business and operating performance could be affected.」

    R&D expenses for the fiscal year were ¥882.042 million. The Company identifies as risks errors in its forecast-based R&D policy and changes in that policy.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for OPTiM yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.